mRNA technology is getting more and more attention, because of its use in COVID-19 vaccines, yet its use is more applicable than for COVID-19 only. Our client eTheRNA is one of the pioneering companies using this technology.
Since the development of COVID-19, the use of mRNA has become more widely known. Yet the potential of this technology is more broad than for prophylaxis only.
Many new mRNA-based medicines are now in clinical trial phases, most of them for different varieties of cancer. BioNTech, Moderna, and our own client eTheRNA are the three pioneering companies using the mRNA technology. Other applications are cardiovascular, autoimmune, and infectious diseases.
More information can be found in the article of Biocentury on mRNA technology.
Want to learn more and read the article? Click here.
